Rock Springs Capital Management LP
Q3 2026 13F filing
Updated 6 days ago107 disclosed positions worth $1.9B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | R REVOLUTION MEDICINES INC | $178.4M | 869.3K | 9.59% | — |
| 2 | T TRAVERE THERAPEUTICS INC | $129.8M | 2.20M | 6.98% | — |
| 3 | L ELI LILLY & CO | $114.2M | 98.7K | 6.14% | — |
| 4 | M MADRIGAL PHARMACEUTICALS INC | $89.3M | 177.2K | 4.80% | — |
| 5 | M MIRUM PHARMACEUTICALS INC | $66.7M | 779.8K | 3.58% | — |
| 6 | R RHYTHM PHARMACEUTICALS INC | $65.9M | 692.6K | 3.55% | — |
| 7 | K KYMERA THERAPEUTICS INC | $45.8M | 409.6K | 2.46% | — |
| 8 | I INSMED INC | $41.7M | 365.3K | 2.24% | — |
| 9 | U UNITEDHEALTH GROUP INC | $33.9M | 92.3K | 1.82% | — |
| 10 | S SCHOLAR ROCK HLDG CORP | $33M | 682.7K | 1.77% | — |
| 11 | A ASCENDIS PHARMA A/S | $32.8M | 144.0K | 1.76% | — |
| 12 | T TENET HEALTHCARE CORP | $31.9M | 125.0K | 1.72% | — |
| 13 | M MINIMED GROUP INC | $31.2M | 1.60M | 1.68% | — |
| 14 | I IRHYTHM HOLDINGS INC | $31.1M | 273.9K | 1.67% | — |
| 15 | I INTUITIVE SURGICAL INC | $29.4M | 72.3K | 1.58% | — |
| 16 | A ARGENX SE | $28.8M | 30.0K | 1.55% | — |
| 17 | H HEARTFLOW INC | $28.6M | 575.0K | 1.54% | — |
| 18 | D DEXCOM INC | $25.3M | 293.5K | 1.36% | — |
| 19 | B BOSTON SCIENTIFIC CORP | $23.4M | 535.0K | 1.26% | — |
| 20 | T TARSUS PHARMACEUTICALS INC | $22.4M | 285.1K | 1.21% | — |
| 21 | A AMYLYX PHARMACEUTICALS INC | $22M | 756.8K | 1.18% | — |
| 22 | C CELLDEX THERAPEUTICS INC NEW | $21.2M | 653.3K | 1.14% | — |
| 23 | A AGILON HEALTH INC | $20.9M | 262.5K | 1.12% | — |
| 24 | Z ZAI LAB LTD | $20.8M | 791.3K | 1.12% | — |
| 25 | E ERASCA INC | $20.6M | 1.41M | 1.11% | — |
| 26 | P PHARVARIS N V | $20.6M | 648.3K | 1.11% | — |
| 27 | G STRUCTURE THERAPEUTICS INC | $20M | 640.3K | 1.08% | — |
| 28 | A ACLARIS THERAPEUTICS INC | $19.9M | 3.79M | 1.07% | — |
| 29 | X XENON PHARMACEUTICALS INC | $19.5M | 524.8K | 1.05% | — |
| 30 | P PENUMBRA INC | $19.1M | 60.0K | 1.03% | — |
| 31 | A AVALYN PHARMACEUTICALS INC | $18.9M | 662.9K | 1.02% | — |
| 32 | P PARABILIS MEDICINES INC | $18.6M | 577.3K | 1.00% | — |
| 33 | N NEUROCRINE BIOSCIENCES INC | $18.5M | 130.5K | 1.00% | — |
| 34 | E ENLIVEN THERAPEUTICS INC | $18M | 393.7K | 0.97% | — |
| 35 | C HEMAB THERAPEUTICS HLDGS INC | $17.7M | 575.4K | 0.95% | — |
| 36 | I INSPIRE MED SYS INC | $16.9M | 244.0K | 0.91% | — |
| 37 | D DANAHER CORP DEL | $16.9M | 76.3K | 0.91% | — |
| 38 | M MBX BIOSCIENCES INC | $16.1M | 275.3K | 0.87% | — |
| 39 | O OMEROS CORP | $16.1M | 847.2K | 0.87% | — |
| 40 | M AGIOS PHARMACEUTICALS INC | $15.7M | 472.3K | 0.84% | — |
| 41 | N NEWAMSTERDAM PHARMA COMPANY | $14.9M | 613.9K | 0.80% | — |
| 42 | D DYNE THERAPEUTICS INC | $14.4M | 891.9K | 0.77% | — |
| 43 | R ULTRAGENYX PHARMACEUTICAL IN | $13.9M | 925.1K | 0.75% | — |
| 44 | Z ZENAS BIOPHARMA INC | $13.5M | 502.1K | 0.73% | — |
| 45 | C CARIS LIFE SCIENCES INC | $13.4M | 438.5K | 0.72% | — |
| 46 | C CYTOKINETICS INC | $13.3M | 201.8K | 0.72% | — |
| 47 | B BRIDGEBIO PHARMA INC | $12.7M | 192.3K | 0.68% | — |
| 48 | C COGENT BIOSCIENCES INC | $12.5M | 389.4K | 0.67% | — |
| 49 | M MINERALYS THERAPEUTICS INC | $12.2M | 485.0K | 0.66% | — |
| 50 | S SUMMIT THERAPEUTICS INC | $12.1M | 715.0K | 0.65% | — |